​Central Nervous System Pharmaceutical Research and Development/Pharmaceutical Sales
30 Enterprise Suite 400 Aliso Viejo CA 92656, Aliso Viejo, CA · KRISTA CLARK
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2016 | AVANIR PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $80,000 | |
| 2016 | AVANIR PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $80,000 | |
| 2016 | AVANIR PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | $110,000 | |
| 2016 | AVANIR PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $110,000 | |
| 2016 | AVANIR PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $180,000 |
| Client | Filings | Total Income |
|---|---|---|
| AVANIR PHARMACEUTICALS | 25 | — |
| Name | Disclosed Prior Position |
|---|---|
| SARAH CHRISTINE D'ORSIE | Director of Advocacy |
| CATHERINE DRATZ FERGUSON | |
| CRYSTAL LYNN VANUCH | Head of Government Affairs |